Pfizer goes back to school

Pfizer Inc. believes its $85 million partnership with the University of California, San Francisco, which creates the first of 8 planned Global Centers for Therapeutic Innovation and brings company scientists to academic medical centers, is the right formula to take early stage biologics research from bench to bedside.

Although the partnership is reminiscent of many industry-...